All stock lists
Cadeler A/S (New York Stock Exchange:CDLR)
DK · Delayed Price · Currency is USD
Industrials · Engineering & Construction
7.41-18.43 (-71.32%)
Market cap
$700M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 26, 2023
Website
Insider Score
––Not scored
CDLR Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From CDLR’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $732.5M
- Net income
- $201.5M
- Net margin
- 27.5%
Leverage2 / 20
Heavily indebted for what it earns.
- Total debt
- $1.60B
- Cash
- $206.2M
- Net debt / EBITDA
- 3.61x
Liquidity15 / 20
Comfortably covers what is due within a year.
- Current assets
- $450.0M
- Current liabilities
- $277.3M
- Current ratio
- 1.62
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- $359.8M
- Free cash flow
- -$331.4M
- FCF margin
- -45.2%
Dilution & runway12 / 20
Some dilution over the past year.
- Shares outstanding
- 96.5M
- Share growth (1y)
- 10.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CDLR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 287.48 M | 124.73 M | 166.00 M | 154.25 M | 233.06 M | 65.47 M |
| Revenue Growth (YoY) | 23.35 % | 90.50 % | 93.13 % | 91.46 % | 269.03 % | 243.46 % |
| Cost of Revenue | 150.97 M | 97.96 M | 77.20 M | 58.59 M | 55.68 M | 44.56 M |
| Gross Profit | 136.52 M | 26.76 M | 88.80 M | 95.66 M | 177.38 M | 20.92 M |
| SG&A Expense | 21.11 M | 19.91 M | 0.00 | 17.63 M | 16.98 M | 16.22 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.11 M | 18.98 M | 23.57 M | 15.97 M | 14.26 M | 16.09 M |
| Operating Income | 115.41 M | 7.79 M | 65.22 M | 79.68 M | 163.12 M | 4.83 M |
| Pretax Income | 95.23 M | -6.85 M | 49.47 M | 66.80 M | 168.10 M | 3.03 M |
| Tax Provision | -1.30 M | 197.00 K | 2.08 M | 2.18 M | 2.16 M | 1.23 M |
| Net Income | 96.52 M | -7.05 M | 47.39 M | 64.61 M | 165.94 M | 1.80 M |
| EPS (Basic) | 1.00 | -0.08 | 0.52 | 0.72 | 1.84 | 0.02 |
| EPS (Diluted) | 1.00 | -0.08 | 0.52 | 0.68 | 1.84 | 0.02 |
| Shares Outstanding | 96.47 M | 88.11 M | 87.72 M | 87.62 M | 87.62 M | 87.72 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.